Cronos Group (NASDAQ:CRON) and Sundial Growers (NASDAQ:SNDL) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation.
This is a summary of current ratings and target prices for Cronos Group and Sundial Growers, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Cronos Group currently has a consensus target price of $19.80, suggesting a potential upside of 137.74%. Sundial Growers has a consensus target price of $10.50, suggesting a potential upside of 227.10%. Given Sundial Growers’ stronger consensus rating and higher probable upside, analysts clearly believe Sundial Growers is more favorable than Cronos Group.
Institutional & Insider Ownership
11.5% of Cronos Group shares are owned by institutional investors. Comparatively, 0.2% of Sundial Growers shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Cronos Group and Sundial Growers’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Cronos Group||$12.12 million||234.53||-$14.64 million||($0.08)||-104.13|
Sundial Growers has lower revenue, but higher earnings than Cronos Group.
This table compares Cronos Group and Sundial Growers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Cronos Group beats Sundial Growers on 6 of the 8 factors compared between the two stocks.
Cronos Group Company Profile
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations MMPR. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.
Sundial Growers Company Profile
Sundial Growers, Inc. produces, distributes, and sells cannabis. It intends to target the premium segment of the adult-use cannabis market. The company was founded by Stanley J. Swiatek and is headquartered in Calgary, Canada.
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.